INVESTMENT

IONISOS

Cold sterilisation of medical devices and pharmaceutical products

Type of investment
:
LBO

Date of investment
:
June 2007

Date of exit
:
December 2004

Location
:
Dagneux (near Lyon)

Chief Executive Officer
:
Michel Gominet

Ionisos is the leader of the French market of cold sterilisation services with a c. 70% market share. The group operates 6 units, including 3 sites featuring gamma irradiation, 2 sites featuring beta irradiation et 1 ethylene oxide site. AtriA Capital Partenaires arranged an MBO on Ionisos in 2007 with the management team.


 Back to the investments

CHOOSE YOUR MUSIC